Morning Movers 08/24: (PPHM) (AVGO) (SWFT) Higher; (PSUN) (IPHI) (UTHR) Lower
Tweet
Share
E-mail
Get Alerts PSUN Hot Sheet
Join SI Premium – FREE
Pacific Sunwear Of California (NASDAQ: PSUN) 35% LOWER; reported Q2 EPS of ($0.29), $0.05 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $214.9 million versus the consensus estimate of $211.8 million. Pacific Sunwear Of California sees Q3 2011 EPS of $-0.16-$-0.29, versus the consensus of $-0.05.
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) 28.2% HIGHER; today announced 20.7 month median overall survival from a prior single-arm Phase II trial evaluating bavituximab in combination with docetaxel in patients with locally advanced or metastatic breast cancer.
Inphi (Nasdaq: IPHI) 27.4% LOWER; sees non-GAAP EPS goes to $0.00 to $0.03 with Q311 revs of $16 to $18 million. Consensus sees EPS of $0.10 and revs of $22.76 million.
United Therapeutics Corporation (NASDAQ: UTHR) 18.2% LOWER; said its FREEDOM-C(2) Phase 3 trial of treprostinil diethanolamine in patients with pulmonary arterial hypertension did not achieve statistical significance for the primary endpoint, six-minute walk distance at Week 16. Deutsche Bank downgraded the stock.
Avago Tech (NASDAQ: AVGO) 11.8% HIGHER; reported Q3 EPS of $0.68, $0.05 better than the analyst estimate of $0.63. Revenue for the quarter came in at $603 million versus the consensus estimate of $594.58 million. Sees Q4 sales up 2-5 percent from the third quarter.
Swift Transportation Co., LLC (Nasdaq: SWFT) 11.8% HIGHER; CEO Jerry C. Moyes bought 280,000 shares on 8/22 at $6.91.
Globe Specialty Metals, Inc. (NASDAQ: GSM) 8.5% LOWER; reported Q4 EPS of $0.28, $0.03 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $175.9 million versus the consensus estimate of $166.71 million.
To get this movers report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) 28.2% HIGHER; today announced 20.7 month median overall survival from a prior single-arm Phase II trial evaluating bavituximab in combination with docetaxel in patients with locally advanced or metastatic breast cancer.
Inphi (Nasdaq: IPHI) 27.4% LOWER; sees non-GAAP EPS goes to $0.00 to $0.03 with Q311 revs of $16 to $18 million. Consensus sees EPS of $0.10 and revs of $22.76 million.
United Therapeutics Corporation (NASDAQ: UTHR) 18.2% LOWER; said its FREEDOM-C(2) Phase 3 trial of treprostinil diethanolamine in patients with pulmonary arterial hypertension did not achieve statistical significance for the primary endpoint, six-minute walk distance at Week 16. Deutsche Bank downgraded the stock.
Avago Tech (NASDAQ: AVGO) 11.8% HIGHER; reported Q3 EPS of $0.68, $0.05 better than the analyst estimate of $0.63. Revenue for the quarter came in at $603 million versus the consensus estimate of $594.58 million. Sees Q4 sales up 2-5 percent from the third quarter.
Swift Transportation Co., LLC (Nasdaq: SWFT) 11.8% HIGHER; CEO Jerry C. Moyes bought 280,000 shares on 8/22 at $6.91.
Globe Specialty Metals, Inc. (NASDAQ: GSM) 8.5% LOWER; reported Q4 EPS of $0.28, $0.03 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $175.9 million versus the consensus estimate of $166.71 million.
To get this movers report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades Target Hospitality (TH) to Buy
- Dollar falls after US Treasury plans more bond buybacks
- Deutsche Bank Starts Ardagh Metal Packaging S.A. (AMBP) at Hold
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Deutsche Bank, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
